A politician tweeted a list showing how much the EU has agreed to pay for leading vaccines, confirming modern-day sky-high price rumors


Secretary of State for Budget Eva de Blaker arrived in Brussels on Friday, November 06, 2020, for a meeting of restricted ministers, in Kern.
Belgian Secretary of State for Budget Eva de Blaker in Brussels on 6 November 2020 Getty Images by Thai Patient / Belga Mag / AFP
  • A Belgian politician tweeted a list on Friday showing how much the EU agrees to pay major drug manufacturers for their vaccine doses.

  • Belgium’s budget secretary of state, Eva de Blaker, was criticized for breach of confidentiality, saying it was “the fault of the communications team.”

  • De Blaker deleted the tweet, but screenshots show that the cheapest Astrazeneca in the EU is priced at $ 2.18, while the most expensive is Moderna, at. 22.06 per dose.

  • A spokesman for De Blicker told the Brussels Times: “We want to provide full transparency, but we are a little more liberal.

  • Visit Business Insider’s homepage for more stories.

A Belgian politician has revealed how much the EU will pay for the main vaccine dose, validating the prediction that the modern vaccine will be the most expensive.

On Friday, Belgium’s budget secretary of state, Eva de Blicker, tweeted a list showing how much the EU pays for the six leading therapies, as well as how many units the government has ordered.

D Blacker quickly deleted the tweet, but not before local news outlets were able to publish screenshots.

D was Blacker Criticism for breach of confidentiality, And Belgian news outlet HLN reported that Gaffe was found guilty of “an error on the part of the communications team.”

Here is the price list shared by D Blacker:

  • Oxford University and AstraZeneca: 2.18 (1.78 euros)

  • Johnson & Johnson: 4 10.42 (8.50 euros)

  • Sanofi and GlaxoSmithKline: .2 9.27 (7.56 euros)

  • Pfizer and Bioentech :. 14.71 (12 euros)

  • Cuerweek: .2 12.26 (10 euros)

  • Modern: .0 22.06 (18 euros)

Business Insider contacted drug manufacturers for comment. Moderna said in August that it expects its vaccine to be the most expensive in development.

The Brussels Times reported that De Blaker tweeted the list amid controversy with the right-wing opposition, which claimed the government had not allocated enough money to buy enough vaccines.

Screenshot shared by De Blaker Shaw, Belgium is buying 33.5 million vaccines at a cost of 279 million euros.

“We want to provide full transparency, but we are a little more liberal,” a De Bliker spokesman told the Times. “Technically, those prices shouldn’t be published, so we removed the tweet.”

Bloomington, Indiana, United States - 2020/12/18: Pfizer Covid-19 vaccine discontinued in a medical syringe used to vaccinate front line health care workers at IU Health Bloomington.  (Photo by Jeremy Hogan / Sopa Images / Photo by Light Rocket)
Close-up of the Pfizer Covid-19 vaccine seen in December 2020. Getty Images by Jeremy Hogan / Sopa Images / Light Rocket

On Friday, a European Commission spokesman said: “We cannot say anything about this case. Everything about vaccines and prices is covered by secrecy clauses, in the interests of society and in the interests of ongoing negotiations.” The Guardian.

The price of vaccines to the EU announced by De Bliker will be different from the costs paid by the US and Canadian selection.

In some cases, European prices may be a reflection of how much funding companies received from EU authorities.

For example, the European Union Pfizer seems to pay 24% less for vaccine shots compared to that, the Guardian said, citing Bernstein Research’s analysis. The EU allocated significant funding to Bioentech, which developed the vaccine for Pfizer.

Similarly, the U.S. The vaccine, produced by AstraZeneca and developed in Oxford, UK, will pay $ 4d, while the EU will pay $ 2.18 (7 1.78), Bernstein said.

The modern vaccine developed in Marsachusetts received 2.5 2.5 billion in funding from the White House and will cost 20% more in Europe, the Guardian said.

It costs 15 in the US, but $ 18 in Europe.

Read the original article on Business Insider